Deer VII & Co’s Dare Bioscience DARE Stock Holding History

Deer VII & Co’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,389	Closed	-$118K	–	3
2016 Q4	$118K	Hold	1,389	–	–	5.03%	4
2016 Q3	$175K	Hold	1,389	–	–	0.1%	5
2016 Q2	$353K	Hold	1,389	–	–	0.16%	6
2016 Q1	$452K	Hold	1,389	–	–	0.12%	6
2015 Q4	$467K	Hold	1,389	–	–	0.11%	6
2015 Q3	$610K	Hold	1,389	–	–	0.58%	5
2015 Q2	$767K	Hold	1,389	–	–	0.31%	6
2015 Q1	$1.5M	Hold	1,389	–	–	0.62%	6
2014 Q4	$1.04M	Hold	1,389	–	–	0.31%	6
2014 Q3	$633K	Sell	1,389 -16	-1%	-$8.53K	0.28%	6
2014 Q2	$880K	Buy	+1,405	New	+$1.08M	0.25%	7

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deer VII & Co's DARE Position: Q1 2017 in Review

Deer VII & Co sold out of Dare Bioscience (DARE) in Q1 2017, closing a stake of 1,389 shares — an estimated $118K sold.

Deer VII & Co first reported a position in DARE in Q2 2014 and held it in 11 quarters. The position peaked at $1.5M in Q1 2015. 27 funds tracked by Wall St. Rank hold DARE as of Q1 2017.

Deer VII & Co reported no remaining Dare Bioscience position as of Q1 2017 after selling out during the quarter.
Deer VII & Co sold 1,389 Dare Bioscience shares in Q1 2017, an estimated $118K.
Deer VII & Co first reported a position in Dare Bioscience in Q2 2014 and held it in 11 quarters.
Deer VII & Co's Dare Bioscience position peaked at $1.5M in Q1 2015.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2017.

Based on Deer VII & Co's 13F filing for Q1 2017, filed 15 May 2017.